Containing novel SARS-CoV-2 variants at source is possible with high-intensity sequencing

Australia News News

Containing novel SARS-CoV-2 variants at source is possible with high-intensity sequencing
Australia Latest News,Australia Headlines
  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 51%

Geneticsequencing could be key to containing future COVID-19 variant outbreaks universityofga PNASNexus

, highlighting that with our parameterization, a 1-week reduction in the delay between exposure and the dissemination of sequencing results has an identical impact onto a five-fold increase in sequencing probability. In contexts where testing is constrained or costly, improvements in sequencing protocols can be decisive.Impact of infection sequencing ratio and sequence processing delays on variant identification. Sample realization of the variant emergence model.

With a doubling time of 7 days, the variant is identified before any infections are exported. For a variant with a 3-day doubling time, four infections are exported before the variant is identified. As the ratio of sequencing delay to doubling time increases, it is necessary to sequence a greater proportion of infections to have the same probability of identifying the variant before exportation,.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

medical_xpress /  🏆 101. in UK

Australia Latest News, Australia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Timely COVID-19 boosters may prevent care facility outbreaksTimely COVID-19 boosters may prevent care facility outbreaksTimely COVID-19 boosters may prevent care facility outbreaks rivm COVID19 coronavirus covid vaccine vaccination booster
Read more »

Review on COVID-19 biomedical waste-derived microplastic toxicityReview on COVID-19 biomedical waste-derived microplastic toxicityIn a new study, researchers reviewed existing literature on the biomedical waste source, elements, and the recent upsurge of microplastics during the SARS-CoV-2 pandemic.
Read more »

Scientists explore kinetics of naturally induced anti-SARS-CoV-2 antibodies in the Kenyan populationScientists explore kinetics of naturally induced anti-SARS-CoV-2 antibodies in the Kenyan populationIn a new study, researchers investigated the breadth and longevity of immunity induced by natural severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposure among the Kenyan population.
Read more »

RNA-dependent RNA polymerase inhibitors in COVID-19 therapyRNA-dependent RNA polymerase inhibitors in COVID-19 therapyA new paper reviews current knowledge of RdRp inhibitors that could be developed further to provide broadly effective antivirals against SARS-CoV-2 in particular and CoVs in general.
Read more »

Researchers explore drug-repurposing candidates acting against nucleotide-binding pockets of multiple SARS-CoV-2 proteinsResearchers explore drug-repurposing candidates acting against nucleotide-binding pockets of multiple SARS-CoV-2 proteinsIn a new study, researchers pursued direct-acting severe acute respiratory syndrome coronavirus-2 drugs that compete for nucleotide-binding pockets (NBPs) of SARS-CoV-2 proteins.
Read more »

Pulmonary radiological patterns in patients diagnosed with SARS-CoV-2 pneumoniaPulmonary radiological patterns in patients diagnosed with SARS-CoV-2 pneumoniaPulmonary radiological patterns in patients diagnosed with SARS-CoV-2 pneumonia UdeGuanajuato pulmonary radiology SARSCoV2 COVID19 coronavirus covid pneumonia
Read more »



Render Time: 2025-03-26 09:20:52